scholarly journals Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open‐label, phase 3, dose‐titration study

2021 ◽  
Author(s):  
Małgorzata Baka‐Ostrowska ◽  
David T. Bolong ◽  
Cristian Persu ◽  
Camilla Tøndel ◽  
Achim Steup ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Detrusor Overactivity ◽  
Dose Titration ◽  
Efficacy And Safety ◽  
Neurogenic Detrusor Overactivity ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Titration Study

scholarly journals Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J)

2019 ◽  
Vol 30 (1) ◽  
pp. 132-140 ◽  
Author(s):  
Mitsumasa Kishimoto ◽  
Atsuo Taniguchi ◽  
Ayako Fujishige ◽  
Shuhei Kaneko ◽  
Sibylle Haemmerle ◽  
...  
Keyword(s):  
Ankylosing Spondylitis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase

scholarly journals Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

2018 ◽  
Vol 54 (1) ◽  
pp. 87-95 ◽  
Author(s):  
Tetsuo Takehara ◽  
Naoya Sakamoto ◽  
Shuhei Nishiguchi ◽  
Fusao Ikeda ◽  
Tomohide Tatsumi ◽  
...  
Keyword(s):  
Japanese Patients ◽  
Decompensated Cirrhosis ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document